Compounds > efaproxiral
Page last updated: 2024-09-03

efaproxiral and Carcinoma, Non-Small Cell Lung

efaproxiral has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayoub, J; Boyd, AP; Cagnoni, PJ; Choy, H; Curran, WJ; Hamburg, S; Kleinberg, L; Kreisman, H; Nabid, A; Roa, W; Scott, C; Smith, C; Souhami, L; Spanos, W; Stea, B1
Boyd, AP; Cagnoni, PJ; Chang, EL; Fortin, A; Kresl, JJ; Mercier, JP; Nabid, A; Senzer, N; Shaw, E; Stea, B; Suh, JH1
Craig, M; Hackman, J; May, J; Pintér, T; Shaw, E; Stea, B; Steffen, RP; Suh, JH1

Trials

3 trial(s) available for efaproxiral and Carcinoma, Non-Small Cell Lung

ArticleYear
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-01, Volume: 23, Issue:25

    Topics: Adult; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Propionates; Radiation-Sensitizing Agents; Survival Analysis

2005
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jan-01, Volume: 24, Issue:1

    Topics: Adult; Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Propionates; Radiation Tolerance; Radiation-Sensitizing Agents

2006
Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases.
    British journal of cancer, 2006, Jun-19, Volume: 94, Issue:12

    Topics: Aniline Compounds; Antisickling Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Male; Middle Aged; Prognosis; Propionates; Survival Analysis

2006